Nirmesh Patel
FounderFounder/Chief Scientific Officer at Cambridge Cancer Genomics
London
Writes $1M – $5M checks · typically $3M
About
Nirmesh Patel is a scientist and entrepreneur who completed a PhD in cancer research, with discoveries that were partnered with major pharmaceutical companies. He co-founded a company focused on matching cancer patients to appropriate therapies, which he grew for over five years before its acquisition in 2021. Patel is now an investor at Amino Collective, where he leads investments in biology and deeptech companies at the pre-seed and seed stages.
Founder/Chief Scientific Officer at Cambridge Cancer GenomicsYC S17
Intro paths
Nirmesh went through Y Combinator (Summer 2017) — any YC alum in your network can reach them through the YC community.
In turn, Nirmesh can intro founders to Cambridge Cancer Genomics's investors below.
Cambridge Cancer Genomics's investors · 4
Co-founders at Cambridge Cancer Genomics

Experience
- Amino CollectiveInvestorcurrent2024 — present
- VALID IncBoard Membercurrent2024 — present
- Stealth Autonomous Lab CoBoard Observercurrent2026 — present
- Stealth Clinical Trial Simulation CoInvestorcurrent2026 — present
- TheoremaInvestorcurrent2026 — present
- Lir TherapeuticsBoard Observercurrent2024 — present
- Founders at the University of CambridgeAdvisorcurrent2023 — present
- Various StartupsInvestorcurrent2017 — present
- Unnatural Products Inc.Board Observer2023 — 2024
- coding.bioBoard Member2022 — 2024
- Orbillion Bio (YC W21)Board Observer2023 — 2024
- EntocycleBoard Observer2023 — 2024
- Pragma BioBoard Advisor2022 — 2024
- The Venture Collective (TVC)Principal2021 — 2024
- Capital EnterpriseEntrepreneur In Residence2021 — 2023
- Dante GenomicsGeneral Manager2020 — 2021
- CCG.ai (acquired by Dante Labs)Co-Founder & Chief Scientific Officer2016 — 2021Greater Cambridge Area
- ForbesEuropean 30 Under 302019
- King's College LondonPHD Student2013 — 2017
- Breakthrough Breast CancerResearch Associate2012 — 2013
Education
- Y CombinatorBatch of S172017
- King's College LondonDoctor of Philosophy (PhD), Oncology and Cancer Biology2013 — 2017
- Quantic School of Business and TechnologyMaster of Business Administration - MBA2019 — 2020
- Cambridge Judge Business SchoolAccelerate2016 — 2017
- King's College LondonMaster's degree, Oncology and Cancer Biology2011 — 2012
- King's College LondonBachelor's degree, Biological and Biomedical Sciences2008 — 2011
Frequently asked questions
- Where does Nirmesh Patel work?
- Nirmesh Patel is Founder/Chief Scientific Officer at Cambridge Cancer Genomics.
- What check size does Nirmesh Patel write?
- Nirmesh Patel typically writes checks of $1M – $5M.
- What companies did Nirmesh Patel found?
- Nirmesh Patel founded Cambridge Cancer Genomics.
Founder mafias
Y Combinator mafia8,732
Also came through, then founded or led a company.
+ 8,725 more
Y Combinator mafia4,701
Also came through, then founded or led a company.
+ 4,694 more
King's College London mafia50
Also came through, then founded or led a company.
+ 43 more
Quantic School of Business and Technology mafia14
Also came through, then founded or led a company.
+ 7 more
Cambridge Judge Business School mafia9
Also came through, then founded or led a company.
+ 2 more
Same school
Also attended Y Combinator2,000
+ 1,994 more
Also attended King's College London222
+ 216 more
Also attended Quantic School of Business and Technology58
+ 52 more
Also attended Cambridge Judge Business School42
+ 36 more








































.avif)



.jpg)














